Moreover, it has been shown that epidermal growth factor receptor (EGFR) is highly expressed in embryonal rhabdomyosarcoma cells and thus may serve as a candidate therapeutic target [33]. This evidence concerns the gene EGFR and rhabdomyosarcoma.